Testing supplemental oxygen for early blood clot in the lungs
Part of Heart & circulation, Lungs & breathing clinical trials.
This early-phase trial studies whether giving extra oxygen can help people with a recently diagnosed lung blood clot (pulmonary embolism). It mainly looks at people who have early symptoms and signs that the right side of the heart is under strain.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are an adult (18 years or older).
- You have a confirmed lung blood clot on imaging within the last 24 hours.
- Your symptoms started or worsened within the last 72 hours.
- A clinician has confirmed right-heart strain (right ventricular dysfunction) on your exam/testing.
- Your oxygen level is at least 90% when breathing room air.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares different real-world treatments for a serious but stable type of blood clot in the lungs (called intermediate-high risk pulmonary embolism). It aims to see which treatments work best in everyday patients, including those with other health conditions.
This trial studies a structured pulmonary (lung) rehabilitation program for people who still have breathing and activity problems after a pulmonary embolism (PE). It may help improve physical ability and function during recovery.
This trial tests a device called the FlowTriever to remove blood clots from the lungs in people with a pulmonary embolism that is not too severe. The goal is to see if this treatment can help improve heart function and symptoms without major surgery.
This Phase 3 trial tests a catheter-based procedure to remove a lung blood clot (pulmonary embolism) and reduce strain on the heart. It may help people who have specific CT scan signs of right-heart strain.
This trial tests a treatment that uses ultrasound to guide a thin tube (catheter) to deliver clot-busting medicine directly into the blood clot in your lung. It may be an option for people whose clot is serious but not yet causing shock, and who have symptoms that started within the last two weeks.
This study uses a special scan (PET/CT) and an inhaled/linked tracer to measure how well air and blood flow work in different lung areas after a pulmonary embolism. It’s meant to better understand regional lung function and how rehabilitation may help some people recover.
Hear when a new Pulmonary Embolism trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.